Advertisement

Topics

Innogenetics Biologicals Company Profile

14:31 EST 21st November 2017 | BioPortfolio

The one-stop-shop for cGMP-compliant Manufacturing, Fill & Finish of Antigens, Bacteria, Viruses and Vaccines.

Our Philosophy is to be "Transparent with your Time and Money".

Expertise :

• Extensive experience with cell-line and process development for manufacturing of proteins, fusion constructs and “recombinant” viruses
• Production of your biologicals of interest in a variety of bacterial or mammalian hosts
• Analytical method development
• Major US and EU Pharmaceutical companies as references
• Formulation and filling, including viruses in a cGMP compliant BL2 facility.

Facility :
• Top class cGMP facility
• Bio-Safety-Level 2 section
• Designed and equipped to facilitate customized production needs

Organization :
• The right Team for your request, in your Time-Frame
• Streamlined follow-through for on-time delivery
• Part of Solvay Pharmaceuticals

Quality :
• Validation according to ICH guidelines
• Development and qualification of a widespread range of analytical methods
• Independent QC team for IPC and release testing
• Independent QA team with QP

Location

Technologiepark 6
Ghent
9052
Belgium

Contact

Phone: 32 9 329 1200
Email: innogeneticsbiologicals@innogenetics.com


News Articles [38 Associated News Articles listed on BioPortfolio]

Australia’s TGA consults on naming of biologicals

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), announced on 28 July 2017 that it was opening a consultation on how to name biologicals.

Switching to biosimilars in Nordic countries

In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...

Switching approaches to biosimilars in Nordic countries

In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...

Amgen and Simcere to collaborate on copy biologicals in China

Biotech giant Amgen and China-based Simcere Pharmaceutical Group (Simcere) announced on 26 September 2017 that they have made an exclusive agreement to co-develop and commercialize four copy biologica...

NHS England to increase biosimilar usage

On 12 September 2017, National Health Service (NHS) England released a ‘Commissioning framework for biological medicines (including biosimilar medicines)’. In this document, they make a serie...

Australian prescribers’ views on biologicals naming and substitution

In a survey of 160 prescribers of biologicals in Australia, over three quarters agreed that the country’s Therapeutic Goods Administration (TGA) should insist on distinct non-proprietary scientific ...

Global Fetal Bovine Serum Market 2012 2022 [Report Updated: 01102016] Prices from USD $3640

SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Standard USDA Standards European Standards OthersBased on ...

Biosimilars and sustainability

Competition between brand-name biologicals and biosimilars has the potential to reduce future cancer costs, according to researchers from Italy [1].

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 20%

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 25%

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China.

Biologicals in the Treatment of Bronchial Asthma.

Biologicals are a therapeutic option for patients with severe asthma. Difficult asthma in patients with untreated comorbidities or persistent trigger factors is much more common than severe refractory...

Clinical development of biologicals and biosimilars - safety concerns.

Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics.

Biologicals are a rapidly expanding class of medications used in the treatment of many different conditions. This article reviews the common characteristics of this class and the requirements for safe...

Early impact of rotavirus vaccination in children less than five years of age in Mozambique.

Mozambique introduced rotavirus vaccine (Rotarix, GSK Biologicals) in the National Immunization Program in September 2015 with the objective of reducing the burden of total diarrheal disease and speci...

Clinical Trials [259 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine co-administered with GSK Biologicals' 10-valent pneumococcal conjugate (GSK1024850A) vaccine ...

Companies [51 Associated Companies listed on BioPortfolio]

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

Affinity Biologicals Inc

Affinity Biologicals Inc. (ABI) is now in it’s sixteenth year as a manufacturer of antibodies and antibody-related products for use in thrombosis and haemostasis research as well as medical diagnost...

Affinity Biologicals Incorporated

Affinity Biologicals Inc. is a manufacturer producing antibodies and antibody-related reagents and plasmas used in thrombosis and hemostasis research and in medical diagnostics manufacturing. A primar...

Pel-Freez Incorporated

Since 1911, Pel-Freez has been committed to providing cost-effective, quality products. Today, Pel-Freez Biologicals manufactures quality animal biologicals for life science research and in vitro diag...

More Information about "Innogenetics Biologicals" on BioPortfolio

We have published hundreds of Innogenetics Biologicals news stories on BioPortfolio along with dozens of Innogenetics Biologicals Clinical Trials and PubMed Articles about Innogenetics Biologicals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innogenetics Biologicals Companies in our database. You can also find out about relevant Innogenetics Biologicals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record